Home・Listă Acțiuni・Tandem Diabetes Care Inc

Tandem Diabetes Care Inc

Închisă

SectorSănătate

18.73 -4.44

Cumpără Vinde

Rezumat

Modificarea prețului

24h

Curent

Minim

18.41

Maxim

19.48

Indicatori cheie
By Trading Economics
Venit	-20M -20M
Vânzări	-43M 247M
EPS	-0.3
Marjă de profit	-8.249
Angajați	2,500
EBITDA	-25M -14M

Recomandări
By TipRanks
Recomandări	Cumpărare
Prognoză pe 12 luni	+43.8% upside

Dividende
By Acuity
Următoarele câștiguri	6 aug. 2026

Statistici piață
By TradingEconomics
Capitalizare de piață	17M 1.4B
Deschiderea anterioară	23.17
Închiderea anterioară	18.73

Sentimentul știrilor

By Acuity

50%

156 / 340 Clasament în Healthcare

Tandem Diabetes Care Inc Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

5 aug. 2026, 19:56 UTC

News

Tandem Diabetes Care Inc's shares are declining amid negative sentiment in the insulin sector following Insulet Corp's lowered revenue growth forecast.

4 aug. 2026, 19:46 UTC

Tandem Diabetes Care Inc shares are lower today, influenced by declines in the Health Care Equipment sub-sector. Earlier, the stock reached a session high before pulling back.

31 iul. 2026, 19:51 UTC

Tandem Diabetes Care Inc is advancing today, benefiting from positive market sentiment driven by technology stocks, despite pulling back from earlier session highs.

30 iul. 2026, 17:11 UTC

Tandem Diabetes Care shares are lower today as the Health Care Equipment sub-sector declines. The asset remains above its 20-day moving average.

29 iul. 2026, 18:15 UTC

Tandem Diabetes Care Inc. shares are higher, driven by significant gains in Health Care Equipment stocks, despite a recent trend of daily price increases.

27 iul. 2026, 19:21 UTC

Tandem Diabetes Care Inc. shares are lower, reflecting broader market trends amid declining oil prices and easing geopolitical tensions ahead of the Federal Reserve meeting.

24 iul. 2026, 14:02 UTC

Tandem Diabetes Care Inc shares are lower today, with no specific news identified. Broader market concerns follow a significant sell-off on Thursday.

21 iul. 2026, 19:06 UTC

Tandem Diabetes Care is lower today, driven by declines in the Health Care Equipment sub-sector. The asset has fallen steadily after an early high.

20 iul. 2026, 17:26 UTC

Tandem Diabetes Care Inc shares are higher today, recovering from an early dip. The stock has gained significantly since last month’s close.

Comparație

Modificare preț

Tandem Diabetes Care Inc Așteptări

Obiectiv de preț

By TipRanks

43.8% sus

Prognoză pe 12 luni

Medie 28.17 USD 43.8%

Maxim 55 USD

Minim 15.5 USD

În baza a 16 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruTandem Diabetes Care Inc - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Cumpărare

16 ratings

Cumpărare

Păstrare

Vânzare

Ținând cont de 16 analiști care au acordat evaluări ale acțiunilor Tandem Diabetes Care Inc - Dist în ultimele 3 luni.

Sentiment

By Acuity

156 / 340 Clasament în Sănătate

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

Despre Tandem Diabetes Care Inc

Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes technology solutions for people living with diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform for managing insulin delivery and display continuous glucose monitoring sensor information directly on the pump home screen; and Tandem Mobi insulin pump, an automated insulin delivery system. It also sells single-use products, including cartridges for storing and delivering insulin, and infusion sets that connect the insulin pump to the user's body. In addition, the company offers Tandem Device Updater used to update the pump software from a personal computer; Tandem Source, a web-based data management platform, which provides a visual way to display diabetes therapy management data from the pumps, integrated CGMs, and supported blood glucose meters; and Sugarmate, a mobile app used to help people visualize diabetes therapy data. It has collaboration agreement with the University of Virginia Center for Diabetes Technology for research and development of fully automated closed-loop insulin delivery systems. The company was formerly known as Phluid Inc. and changed its name to Tandem Diabetes Care, Inc. in January 2008. Tandem Diabetes Care, Inc. was incorporated in 2006 and is headquartered in San Diego, California.